A viral blip is a single detectable viral load result in someone who is otherwise consistently suppressed, usually a low figure in the tens or low hundreds, followed by a return to undetectable at the next test. They are common, they are usually not clinically significant, and they do not alter the transmission position.
What causes them?
Several things, most of them mundane. A recent vaccination or a current infection causes immune activation that can briefly release virus from cells where it was latent. Laboratory assays have inherent variability at very low levels, so a result of sixty and a result of undetectable may represent the same underlying state. Occasionally a brief lapse in adherence is responsible.
Do they affect transmission?
No. The evidence base for untransmittability uses a threshold of two hundred copies per millilitre, deliberately set above the usual reporting threshold of fifty precisely to accommodate these fluctuations. A single blip in someone otherwise consistently suppressed sits well within what the studies encompassed, and participants in those trials will have had blips without any transmissions occurring.
When does a rise actually matter?
When it is sustained rather than isolated, when it is above two hundred, or when it forms part of an upward trend across several tests. Two consecutive results above two hundred generally prompt investigation. At that point the position on transmission is no longer established, and it is reasonable to use condoms or for a partner to consider PrEP until suppression is regained.
What does the clinic do about a blip?
Usually repeats the test rather than acting on it. If the repeat is undetectable, nothing further is needed. If it is not, they will look at adherence, at whether anything is interfering with absorption, and at whether resistance testing is warranted. Resistance testing requires a viral load above a certain level to work, which is one reason a sustained rise is investigated rather than watched.
What interferes with absorption?
Antacids and supplements containing calcium, magnesium, iron or zinc bind integrase inhibitors in the gut and can reduce drug levels substantially if taken at the same time. This is a common and easily fixed cause of unexplained rises, and it is worth mentioning everything you take rather than only prescribed items.
Should you tell a partner about a blip?
A judgement call. It does not change the transmission position, so there is no safety reason to. Some people mention it because they would rather share the full picture, and others do not because explaining a technicality tends to generate anxiety out of proportion to its meaning. If you do mention it, being clear that it does not affect transmission is the part that matters.
How do you avoid worrying about them?
By reading the trend rather than any single number. Ask for your results at each appointment and keep a note, so a figure of eighty in an otherwise flat line looks like what it is. People who see only individual results without context understandably read every fluctuation as significant.
Does anything reduce how often they happen?
Consistent dosing at roughly the same time, and keeping antacids and mineral supplements several hours away from an integrase inhibitor. Beyond that, blips are largely outside your control and are not evidence of doing anything wrong. Vaccination-related blips in particular are a sign the immune system is working rather than failing.
What should prompt a call?
A result above two hundred, a rise across consecutive tests, or a period where you know adherence has slipped. Contact the clinic rather than waiting for the next appointment, because the earlier a sustained rise is addressed, the more options remain.
How common are they?
Common enough that most people on long-term treatment will see at least one. Their frequency is one reason the untransmittability threshold was set at two hundred rather than at the reporting limit, since a definition that a single blip could breach would be unusable in practice.
Do they mean resistance is developing?
Usually not. Isolated low-level blips have not been shown to predict later treatment failure in people who are otherwise adherent. A pattern of rising results is a different signal, and that is what clinicians watch for.